Description: Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Home Page: www.medicover.com
P.O. Box 5283
Stockholm,
102 46
Sweden
Phone:
46 8 40 01 76 00
Officers
| Name | Title |
|---|---|
| Mr. Fredrik Rågmark | CEO & Director |
| Mr. Joe Ryan | Chief Financial Officer |
| Mr. Jaroslaw Urbanczyk | Chief Information Officer |
| Hanna Bjellquist | Head of Investor Relations |
| Ms. Jenny Brandt | Gen. Legal Counsel |
| Dr. Andrew Vallance-Owen | Chief Marketing Officer |
| Ms. Liselotte Bergmark | Group Human Resource Director |
| Mr. John Paul Stubbington | Chief Operating Officer of Healthcare Services |
| Mr. Staffan Ternstrom | Chief Operating Officer for Diagnostic Services |
| Mr. Marcin Radziwill | Chief Exec. Officer of Medicover Foundation |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| Forward PE: | 44.6429 |
|---|---|
| Trailing PE: | 51.5 |
| Price-to-Book MRQ: | 4.4464 |
| Price-to-Sales TTM: | 1.3793 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 38000 |